Skip to main content
Oculis Holding AG logo

Oculis Holding AG — Investor Relations & Filings

Ticker · OCS ISIN · CH1242303498 LEI · 5067005370C2KK324336 IC Manufacturing
Open in API
Filings indexed 321 across all filing types
Latest filing 2025-03-20 Director's Dealing
Country CH Switzerland
Listing IC OCS

About Oculis Holding AG

https://www.oculis.com/

Oculis Holding AG is a global, clinical-stage biopharmaceutical company focused on developing innovative therapies for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs. The company's pipeline aims to transform current treatment paradigms. Key candidates include OCS-01, a topical eye drop using the proprietary OPTIREACH® technology, investigated as a potential first non-invasive treatment for Diabetic Macular Edema (DME). Another lead asset is Privosegtor, a novel peptoid small molecule being developed as a neuroprotective therapy for optic neuropathies such as Acute Optic Neuritis. The pipeline also features Licaminlimab, an anti-TNFα eye drop candidate for treating Dry Eye Disease.

Recent filings

Filing Released Lang Actions
PDMR notification - R. Sherif - sales 17 Mar 2025.pdf
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions by persons discharging managerial responsibilities (PDMRs), specifically detailing a sale of ordinary shares by the CEO, Riad Sherif, of Oculis Holding AG. This type of disclosure is explicitly defined as a 'Director's Dealing' (DIRS) in the provided filing categories, as it reports personal share transactions by company executives.
2025-03-20 English
PDMR notification - R. Sherif - sales 18 Mar 2025.pdf
Director's Dealing Classification · 100% confidence The document is a standard template for the notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs). It explicitly identifies the person (Riad Sherif, CEO), the issuer (Oculis Holding AG), the nature of the transaction (sale of ordinary shares), and provides detailed price and volume data. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing, which covers insider trades by executives.
2025-03-20 English
PDMR notification - R. Sherif - sales 19 Mar 2025.pdf
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions by persons discharging managerial responsibilities (PDMRs), specifically detailing a sale of ordinary shares by the CEO, Riad Sherif. This type of disclosure is required under market abuse regulations (MAR) and is classified as a Director's Dealing (DIRS) report.
2025-03-20 English
Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities
Director's Dealing Classification · 95% confidence The document is a short announcement regarding 'Notifications of Transactions by Person Discharging Managerial Responsibilities' (PDMR). While it concerns insider trading, the document itself is a brief notification/announcement of these transactions rather than the detailed disclosure form itself. Given the context of reporting trades by executives, it falls under the category of Director's Dealing.
2025-03-20 English
Oculis Publishes Notifications of T..
Director's Dealing Classification · 100% confidence The document is a standardized template titled "Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them." It details a sale of ordinary shares by Riad Sherif, the Chief Executive Officer, executed pursuant to a 10b5-1 trading plan. This type of filing specifically reports personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (DIRS).
2025-03-20 English
Notification of managers transaction - Lionel Carnot - March 2025 purchase.pdf
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions by persons discharging managerial responsibilities (PDMRs), specifically detailing a purchase of ordinary shares by a member of the Board of Directors (Lionel Carnot) of Oculis Holding AG. This type of disclosure is explicitly defined under the 'Director's Dealing' category, which covers personal share transactions by company directors and executives.
2025-03-14 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.